SKIP000921 | |
SKIP ID | SKIP000921 |
Organism(En) | - |
Organism(Ja) | - |
Cell Type(En) | - |
Cell Type(Ja) | - |
Cell Tissue(En) | fibroblast |
Cell Tissue(Ja) | 線維芽細胞 |
Cell Origin | Diseased |
Cell Name 1(En) | SLE#20J |
Cell Name 1(Ja) | SLE#20J |
Cell Name 2(En) | - |
Cell Name 2(Ja) | - |
Disease Name 1(Ja) | 全身性紅斑性狼瘡 |
ICD Code 1 | M32.9 |
Disease Name 1(En) | Systemic lupus erythematosus |
OMIM1 | 152700 |
Disease Name 2(Ja) | - |
ICD Code 2 | - |
Disease Name 2(En) | - |
OMIM 2 | - |
Disease Name 3(Ja) | - |
ICD Code 3 | - |
Disease Name 3(En) | - |
OMIM 3 | - |
Age | - |
Age Range | -- |
Sex | -- |
Race(En) | - |
Race(Ja) | - |
Genetic Diagnosis | No |
Not Detected | No |
Description(En) | iPS cell line |
Description(Ja) | iPS cell line |
Cell Morphology | human ES-like |
Grade | Research Grade |
Vector | Lentivirus |
Transgene | OCT3/4, SOX2, c-MYC and KLF4 |
Adhesiveness | Yes |
Feeder | No |
Feeder Cell | - |
Medium | HEScGRO (catalog number SCM020; Millipore, Billerica, MA, USA) with 25% mTeSR1 medium (catalog number 05850; Stem Cell Technologies, Vancouver, BC, Canada) and antibiotics, but no additional basic fibroblast growth factor.. |
Genome Editing | - |
CO2 | - |
Mycoplasma | - |
Detection of Contaminants Mycoplasma | - |
Pluripotent Markers | Yes |
Pluripotent Markers Assay | immunostaining |
in vitro Differentiation | Yes |
in vitro Differentiation Assay | Differentiation to three germ layers |
in vivo Differentiation | Yes |
in vivo Differentiation Assay | teratoma formation |
Other 1 Assay | - |
Other 1 Assay Method | - |
Other 2 Assay | - |
Other 2 Assay Method | - |
Other 3 Assay | - |
Other 3 Assay Method | - |
Karyotype | - |
Karyotype Assay | - |
Remaining Vector Detection | - |
Remaining Vector Detection Assay | - |
STR | - |
HLA | - |
Stem Cell Transcriptome analysis | - |
Stem Cell Transcriptome analysis Assay | - |
Author Name(En) | Tayaramma Thatava |
Author Name(Ja) | Tayaramma Thatava |
Author Organization(En) | Department of Molecular Medicine, Mayo Clinic |
Author Organization(Ja) | Department of Molecular Medicine, Mayo Clinic |
Author Contact Email | ikeda[dot]yasuhiro[at]mayo[dot]edu |
PI Organization(En) | - |
PI Organization(Ja) | - |
PI Name(En) | - |
PI Name(Ja) | - |
PI Contact Email | - |
Availability | Information Only |
Provider Organization(En) | Department of Molecular Medicine, Mayo Clinic |
Provider Organization(Ja) | Department of Molecular Medicine, Mayo Clinic |
Provider Email | ikeda[dot]yasuhiro[at]mayo[dot]edu |
Provider URL | - |
Ethical Statement(En) | - |
Ethical Statement(Ja) | - |
Terms of Use(En) | - |
Terms of Use(Ja) | - |
PubMed ID | 22142803 |
DOI | 10.1186/scrt89 |
Title | Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. |
Authors | Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y |
Journal | Stem Cell Res Ther |
Year | 2011 |
Volume | 2 |
Issue | 6 |
Pages | 48 |
URL | http://www.ncbi.nlm.nih.gov/pubmed/22142803 |
Free input | - |
Note | - |